Pharma and Biotech Quality Summit

Explore how quality functions are evolving into strategic, risk-based and digitally enabled systems in response to increasing regulatory complexity and innovation in pharmaceuticals and biotechnology.

The Pharma & Biotech Quality Summit 2026, hosted by Fleming Pharma and Biotech Events, will take place on 12–13 May in Munich, bringing together senior quality and compliance professionals from across the European pharmaceutical and biotechnology sectors. The event focuses on how quality functions are evolving in response to increasing regulatory expectations, digital transformation, and the growing complexity of modern therapies. Key topics include risk-based quality management, Annex 1 implementation and contamination control strategies, AI-enabled quality systems, and maintaining data integrity in highly regulated environments.

Designed for decision-makers and technical leaders, the two-day programme features keynote presentations, case studies, panel discussions, and interactive workshops. Attendees will hear from experts representing leading organisations such as Pfizer, Novo Nordisk, and Takeda Pharmaceutical Company, alongside regulatory perspectives from the Medicines and Healthcare products Regulatory Agency and the International Society for Pharmaceutical Engineering. With a strong emphasis on practical application and peer-to-peer exchange, the summit offers valuable insights for those looking to strengthen quality systems and ensure continuous inspection readiness.